Literature DB >> 8135757

Identification of serines-967/968 in the juxtamembrane region of the insulin receptor as insulin-stimulated phosphorylation sites.

F Liu1, R A Roth.   

Abstract

A line of Chinese hamster ovary cells overexpressing protein kinase C alpha was transfected with cDNAs encoding either the wild-type human insulin receptor or one of two mutant insulin receptors with either Ser-967 and -968 or -974 and -976 in the juxtamembrane region changed to alanine. Both mutant receptors exhibited normal insulin-activated tyrosine kinase activity as assessed by either autophosphorylation or insulin-stimulated increases in anti-phosphotyrosine-precipitable phosphatidylinositol 3-kinase. The wild-type and mutant insulin receptors were also examined for serine and threonine phosphorylation in response to insulin and activation of protein kinase C. To visualize Ser/Thr-phosphorylation sites of the receptor better in response to insulin, the receptor from in vivo-labelled insulin-treated cells was first treated with a tyrosine-specific phosphatase to remove all tyrosine phosphorylation. Phosphopeptides from the three receptors were analysed by high-percentage polyacrylamide/urea gel electrophoresis and two-dimensional t.l.c. The mutant receptor lacking Ser-967 and -968 but not the mutant lacking Ser-974 and -976 was found to be missing phosphorylated peptides in response to insulin and, to a lesser extent, after activation of protein kinase C. However, the insulin-stimulated increase in anti-phosphotyrosine-precipitable phosphatidylinositol 3-kinase was inhibited to the same extent by activation of protein kinase C in cells expressing the two mutant receptors as in cells expressing the wild-type receptor. These results indicate that these four serine residues in the juxtamembrane region are not major regulatory sites of the intrinsic tyrosine kinase activity of the insulin receptor by protein kinase C, although Ser-967 and/or -968 appear to be phosphorylated in response to insulin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8135757      PMCID: PMC1137964          DOI: 10.1042/bj2980471

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  38 in total

1.  Regulation of the insulin receptor kinase by hyperinsulinism.

Authors:  J L Treadway; J Whittaker; J E Pessin
Journal:  J Biol Chem       Date:  1989-09-05       Impact factor: 5.157

Review 2.  Cellular alterations in liver, skeletal muscle, and adipose tissue responsible for insulin resistance in obesity and type II diabetes.

Authors:  J F Caro; L G Dohm; W J Pories; M K Sinha
Journal:  Diabetes Metab Rev       Date:  1989-12

3.  Two systems in vitro that show insulin-stimulated serine kinase activity towards the insulin receptor.

Authors:  D M Smith; M J King; G J Sale
Journal:  Biochem J       Date:  1988-03-01       Impact factor: 3.857

Review 4.  Insulin receptor signaling. Activation of multiple serine kinases.

Authors:  M P Czech; J K Klarlund; K A Yagaloff; A P Bradford; R E Lewis
Journal:  J Biol Chem       Date:  1988-08-15       Impact factor: 5.157

5.  Identification of a phosphorylation site of the rat insulin receptor catalyzed by protein kinase C in an intact cell.

Authors:  O Koshio; Y Akanuma; M Kasuga
Journal:  FEBS Lett       Date:  1989-08-28       Impact factor: 4.124

Review 6.  Okadaic acid: a new probe for the study of cellular regulation.

Authors:  P Cohen; C F Holmes; Y Tsukitani
Journal:  Trends Biochem Sci       Date:  1990-03       Impact factor: 13.807

7.  Insulin-sensitive phosphorylation of serine 1293/1294 on the human insulin receptor by a tightly associated serine kinase.

Authors:  R E Lewis; G P Wu; R G MacDonald; M P Czech
Journal:  J Biol Chem       Date:  1990-01-15       Impact factor: 5.157

8.  Mutation of the insulin receptor at tyrosine 960 inhibits signal transmission but does not affect its tyrosine kinase activity.

Authors:  M F White; J N Livingston; J M Backer; V Lauris; T J Dull; A Ullrich; C R Kahn
Journal:  Cell       Date:  1988-08-26       Impact factor: 41.582

9.  Studies on the autophosphorylation of the insulin receptor from human placenta. Analysis of the sites phosphorylated by two-dimensional peptide mapping.

Authors:  J M Tavaré; R M Denton
Journal:  Biochem J       Date:  1988-06-01       Impact factor: 3.857

10.  Phorbol esters induce insulin receptor phosphorylation in transfected fibroblasts without affecting tyrosine kinase activity.

Authors:  M P Coghlan; K Siddle
Journal:  Biochem Biophys Res Commun       Date:  1993-05-28       Impact factor: 3.575

View more
  5 in total

1.  Studies on an insulin-stimulated insulin receptor serine kinase activity: separation of the kinase activity from the insulin receptor and its reconstitution back to the insulin receptor.

Authors:  K A Asamoah; P G Atkinson; W G Carter; G J Sale
Journal:  Biochem J       Date:  1995-06-15       Impact factor: 3.857

2.  Site-specific anti-phosphopeptide antibodies: use in assessing insulin receptor serine/threonine phosphorylation state and identification of serine-1327 as a novel site of phorbol ester-induced phosphorylation.

Authors:  M P Coghlan; T S Pillay; J M Tavaré; K Siddle
Journal:  Biochem J       Date:  1994-11-01       Impact factor: 3.857

3.  Glucose-induced phosphorylation of the insulin receptor. Functional effects and characterization of phosphorylation sites.

Authors:  T S Pillay; S Xiao; J M Olefsky
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

4.  Impairment of the liver insulin receptor autoactivation cascade at full-term pregnancy in the rat.

Authors:  C Martinez; J C Molero; P Ruiz; A Del Arco; A Andres; J M Carrascosa
Journal:  Biochem J       Date:  1995-10-15       Impact factor: 3.857

5.  APPL1 mediates adiponectin-induced LKB1 cytosolic localization through the PP2A-PKCzeta signaling pathway.

Authors:  Sathyaseelan S Deepa; Lijun Zhou; Jiyoon Ryu; Changhua Wang; Xuming Mao; Cai Li; Ning Zhang; Nicolas Musi; Ralph A DeFronzo; Feng Liu; Lily Q Dong
Journal:  Mol Endocrinol       Date:  2011-08-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.